Background
==========

An increasing number of patients are being hospitalized for sepsis, although the overall mortality rate among patients with sepsis is declining ([@ref-30]; [@ref-2]; [@ref-21]). Nevertheless, an increase in severe sepsis with organ failure can be observed ([@ref-21]; [@ref-57]). Therefore, close monitoring and risk stratification of sepsis patients is crucial for proper treatment and consequently patient outcome.

Sepsis is characterized by a proinflammatory and procoagulatory shift that can induce life-threatening complications in response to dangerous and pathogen-associated molecular patterns, whereby both systems interact in a complex way ([@ref-24]). When immune response and coagulation become exaggerated during sepsis, tissue and organ damage occur ([@ref-46]). Consequently, hemostatic disorders contribute significantly to organ dysfunction and the high lethality of sepsis ([@ref-45]).

One key factor in coagulation is fibrinogen, which also has many immunomodulating properties ([@ref-5]; [@ref-36]). It is a player of the direct host defense in that it builds a physical barrier against invading pathogens when forming fibrin fibers ([@ref-5]). Additionally, fibrinogen and its cleavage products have antimicrobial properties against certain bacteria ([@ref-36]), creating a new link between the innate immune system and blood coagulation.

Platelet count and antithrombin levels change according to the course of sepsis ([@ref-23]; [@ref-44]). Antithrombin has anti-inflammatory properties, while platelets play a crucial role in inflammatory response in addition to their role in coagulation and fibrinolysis ([@ref-35]; [@ref-15]). Only in extreme concentrations are leukocytes associated with the progression of sepsis, where the leukocyte count is itself part of the definition of sepsis ([@ref-25]; [@ref-6]; [@ref-26]).

A direct association between sepsis and elevated C-reactive protein levels has been described in several studies ([@ref-41]; [@ref-31]; [@ref-38]; [@ref-59]; [@ref-47]; [@ref-39]). This acute phase protein is suitable as a daily measurement to monitor the course of sepsis and can be regarded as an indicator of successful treatment ([@ref-59]).

However, our understanding is limited as to how the various components of the inflammatory and coagulatory systems interact in different clinical situations and underlying diseases although activation of inflammatory and coagulation pathways is important in the pathogenesis of sepsis. The clinical picture of sepsis is very heterogeneous and ranges from relatively minor systemic damage to septic shock with multiple-organ failure ([@ref-25]; [@ref-14]). The patient clientele also differs greatly depending on constitution and underlying diseases. The aim of this study was to evaluate routinely measured inflammation and coagulation parameters for their predictive power in the course of sepsis.

Methods
=======

This is a retrospective analysis of 1,110 septic patients at the medical, post-surgical and trauma Intensive Care Units (ICU) of Innsbruck Medical University Hospital, Austria. The data set contains clinical data and routine laboratory parameters.

Inclusion of patients
---------------------

Patients with the diagnosis of sepsis or systemic infection, who were treated at the medical, post-surgical and trauma ICUs between November 2000 and July 2013 with suspected or proven infection were respectively screened for study inclusion.

Patients meeting the sepsis criteria according to the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) international sepsis definitions based on a proven or strongly suspected infection with at least two of the SIRS criteria were included in the study ([@ref-6]; [@ref-26]). No exclusion criteria were defined. The study was approved by the institutional review board of the Medical University of Innsbruck (AN2013-0043).

Data collection
---------------

Demographic variables such as age, sex and the diagnosed underlying disease were recorded. The C-reactive protein (CRP) level during the septic episode was used to harmonize the progression of sepsis between the patients. We chose peak of C-reactive protein since this parameter reflects the inflammatory process and is widely used in clinical routine for the surveillance of inflammatory diseases. Many studies have described an interrelation between an elevated C-reactive protein level and sepsis ([@ref-41]; [@ref-31]; [@ref-38]; [@ref-39]).

Inflammatory and coagulatory routine parameters such as fibrinogen, platelets, antithrombin, prothrombin time (PT), activated partial thromboplastin time (aPTT), bilirubin and leukocytes were collected on the day of the peak C-reactive protein. In-hospital mortality was chosen as the main outcome parameter.

Statistical analysis
--------------------

A mathematician not involved in the study procedures and patient assessment (TH) was responsible for the statistical analyses using R, version 3.4.1. All statistical assessments were two-sided and a significance level of 5% was used.

Patients with only one missing parameter on the day of C-reactive protein peak were included in the analyses. Simple mean imputation was deemed sufficient to deal with missing data, i.e., not inducing significant bias. C-reactive protein, fibrinogen, platelets, antithrombin, aPTT, PT, bilirubin and leukocytes measured at the peak level of C-reactive protein entered model selection according to the Bayesian Information Criterion (BIC) for expectation maximization (EM) initialized by hierarchical clustering for parameterized Gaussian mixture models using the R package mclust ([@ref-13]). Gaussian mixture models are used to identify subpopulations within an overall population. Such models do not require knowledge of the subpopulation to which a patient belongs, thus permitting the model to automatically learn the subpopulations. For more details we refer to [@ref-13].

We descriptively present the resulting clusters by depicting the constituting variables via boxplots. Patient characteristics and outcome variables are presented as n (%) for binary data and continuous data as medians (25th to 75th percentile).

Differences between clusters are assessed with Pearson's Chi-squared test for binary variables and the Kruskal-Wallis test for continuous variables; pairwise differences with the Wilcoxon rank sum test and Fisher's exact test. We provide Kaplan--Meier curves for survival during 28 days after peak C-reactive protein stratified by the clusters and assess differences in survival using the log-rank test. A Cox proportional hazards regression model for survival stratified by the clusters was fitted and corresponding hazard ratios are provided, with 95% confidence intervals.

Results
=======

A total of 1,110 patients met the sepsis criteria according to criteria defined by the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) international sepsis definitions based on a proven or strongly suspected infection with at least two of the SIRS criteria ([@ref-6]; [@ref-26]).

79 patients were excluded from the final analysis because more than one of the analyzed parameters at the peak level of C-reactive protein was missing. The percentage of missing values in the remaining 1031 patients was 1.79%. C-reactive protein, fibrinogen, platelets, antithrombin, aPTT, PT, bilirubin and leukocytes at the peak level of C-reactive protein entered the model selection according to the Bayesian Information Criterion (BIC) for expectation maximization (EM) initialized by hierarchical clustering for parameterized Gaussian mixture models. A challenging task is to select the best model from a large class of models. A well established approach in the context of Gaussian mixture models uses the Bayesian Information Criterion (BIC) for expectation maximization. In [Fig. 1](#fig-1){ref-type="fig"} the BIC is given for all cluster solutions, depending on the number of clusters. The various cluster solutions are labeled with the abbreviations of the respective model. A list of all models is available in [@ref-13]. The VVE (ellipsoidal, equal orientation) model with five clusters achieves the largest BIC value and was consequently selected.

![Bayesian Information Criterion (BIC) for expectation maximization (EM).\
BIC for all considered Gaussian mixture models with one to nine components. The highest BIC value is achieved by the VEE model with 5 components and consequently this clustering was selected.](peerj-07-7147-g001){#fig-1}

Patient population
------------------

In our patient population, men (65.5%) were more prevalent than women. Average age was 65 years and the majority of patients suffered from cardiovascular disease followed by complications of the digestive tract, as for example bowel perforation. The patients were severely ill and at ICU admission had a SAPS 3 score of 72 points and a SOFA score of 10 points. Of the patients 81.5% needed catecholamine therapy and 97.6% required mechanical ventilation.

Cluster analysis
----------------

The resulting five clusters (C1-C5) consisted of 336, 364, 105, 148 and 78 patients, respectively. Those clusters constituted profiles of patients presenting a similar pattern of routinely measured parameters at the peak level of C-reactive protein in sepsis ([Fig. 2](#fig-2){ref-type="fig"}). All parameters differ significantly between the clusters (*p* \< 0.0001).

![Cluster Analysis of routinely measured parameters at C-reactive protein peak.\
Boxplots of C-reactive protein (A), fibrinogen (B), platelets (C), antithrombin (D), bilirubin (E), aPTT (F), PT (G), and leukocytes (H). Parameters are depicted for cluster 1 (green), cluster 2 (blue), cluster 3 (golden), cluster 4 (orange), and cluster 5 (red) in (A to H).](peerj-07-7147-g002){#fig-2}

The distinct patterns of parameters in the various clusters also reflected the type and severity of already existing diseases as SAPS 3 score increases from Cluster 1 to Cluster 5 (see [Table 1](#table-1){ref-type="table"}). Correspondingly, 28-day mortality rose towards Cluster 5 (see [Fig. 3](#fig-3){ref-type="fig"}) and differed significantly between clusters (*p* \< 0.0001). Except for C1 and C2 as well as C2 and C3, which did not significantly differ from each other (*p* = 0.2576 and *p* = 0.2329, respectively), all other pairwise differences in 28-day survival were significant (see [Table 2](#table-2){ref-type="table"}).
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###### Patient characteristics.[^a^](#table-1fn1){ref-type="fn"}

![](peerj-07-7147-g006)

                                                                                           **CLUSTER**                                                                                                        
  ----------------------------------------------------------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------
  Male gender                                                       675 (65.5%)            219 (65.2%)            242 (66.5%)            67 (63.8%)             94 (63.5%)             53 (67.9%)             0.9426
  Age (years)                                                       65(53--75)             64(51--73)             69.5(56--77)           61(51--72)             64.5 (55.75--74)       61.5 (47.25--74.75)    0.0002
  BMI (kg/m^2^)                                                     25.39 (22.58--29.38)   25.95 (22.98--30.13)   24.67 (21.99--28.41)   26.12 (23.41--29.39)   25.71 (23.29--30.44)   24.22 (22.17--28.58)   0.026
  **Diagnosed underlying disease**                                                                                                                                                                            
  Cardiovascular                                                    568 (55.1%)            167 (49.7%)            222 (61%)              45 (42.9%)             84 (56.8%)             50 (64.1%)             0.0012
  Central nervous system                                            275 (26.7%)            111 (33%)              87 (23.9%)             31 (29.5%)             27 (18.2%)             19 (24.4%)             0.0061
  Digestive tract                                                   379 (36.8%)            115 (34.2%)            143 (39.3%)            48 (45.7%)             51 (34.5%)             22 (28.2%)             0.0799
  Kidney                                                            240 (23.3%)            70 (20.8%)             87 (23.9%)             22 (21%)               31 (20.9%)             30 (38.5%)             0.0171
  Liver                                                             137 (13.3%)            25 (7.4%)              52 (14.3%)             8 (7.6%)               26 (17.6%)             26 (33.3%)             \<0.0001
  Respiratory                                                       351 (34%)              111 (33%)              133 (36.5%)            37 (35.2%)             44 (29.7%)             26 (33.3%)             0.6497
  Skin                                                              101 (9.8%)             38 (11.3%)             30 (8.2%)              15 (14.3%)             10 (6.8%)              8 (10.3%)              0.2124
  Oncologic                                                         191 (18.5%)            50 (14.9%)             69 (19%)               23 (21.9%)             33 (22.3%)             16 (20.5%)             0.2491
  Need for catecholamines[^c^](#table-1fn3){ref-type="fn"}          787 (81.5%)            213 (67.6%)            279 (80.2%)            79 (81.4%)             113 (86.3%)            62 (82.7%)             0.0136
  Mechanical ventilation[^d^](#table-1fn4){ref-type="fn"}           727 (97.6%)            225 (97.4%)            271 (97.7%)            78 (100%)              95 (96.9%)             58 (98.3%)             0.6671
  SOFA score[^e^](#table-1fn5){ref-type="fn"}                       10 (8--12.25)          9 (7--11)              11 (9--12)             9 (7--11)              12 (10--14)            13 (11--16)            \<0.0001
  SAPS 3[^e^](#table-1fn5){ref-type="fn"} predicted mortality (%)   61 (40--79)            52 (32--72)            62 (46--78)            60 (41--78)            72 (50--83.25)         78 (48--89)            \<0.0001
  SAPS 3[^e^](#table-1fn5){ref-type="fn"} score                     72 (62--84)            68 (58--79)            73 (65--83)            72 (62.5--83)          79 (67--88.25)         83 (66--95)            \<0.0001

**Notes.**

Binary data are presented as *n* (%), continuous data as medians (25th to 75th percentile).

Assessed with Pearson's chi-squared test for binary variables and the Kruskal--Wallis test for continuous variables.

Not assessable for 65 patients.

Not assessable for 286 patients.

At admission, not assessable for 307 patients.

![Kaplan--Meier curves for 28-day survival.\
Kaplan--Meier curves are depicted for cluster 1 (green), cluster 2 (blue), cluster 3 (golden), cluster 4 (orange), and cluster 5 (red).](peerj-07-7147-g003){#fig-3}
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###### Outcome.[^a^](#table-2fn1){ref-type="fn"}
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                                                              **CLUSTER**                                                          
  --------------------------------------------- ------------- ------------- ------------- ------------ ------------- ------------- ----------
  7-day                                         195 (18.9%)   32 (9.5%)     62 (17%)      24 (22.9%)   45 (30.4%)    32 (41%)      \<0.0001
  28-day                                        291 (28.2%)   60 (17.9%)    89 (24.5%)    31 (29.5%)   64 (43.2%)    47 (60.3%)    \<0.0001
  In-hospital                                   314 (30.5%)   70 (20.8%)    92 (25.3%)    35 (33.3%)   65 (43.9%)    52 (66.7%)    \<0.0001
  **Organ failure**                                                                                                                
  Cardiovascular system                         613 (59.5%)   169 (50.3%)   210 (57.7%)   66 (62.9%)   108 (73%)     60 (76.9%)    \<0.0001
  Central nervous system                        341 (33.1%)   109 (32.4%)   131 (36%)     34 (32.4%)   39 (26.4%)    28 (35.9%)    0.3102
  Intestine                                     207 (20.1%)   55 (16.4%)    75 (20.6%)    29 (27.6%)   29 (19.6%)    19 (24.4%)    0.1084
  Kidney                                        584 (56.6%)   150 (44.6%)   223 (61.3%)   54 (51.4%)   96 (64.9%)    61 (78.2%)    \<0.0001
  Liver                                         291 (28.2%)   39 (11.6%)    111 (30.5%)   32 (30.5%)   59 (39.9%)    50 (64.1%)    \<0.0001
  Respiratory                                   591 (57.3%)   177 (52.7%)   209 (57.4%)   67 (63.8%)   90 (60.8%)    48 (61.5%)    0.1938
  Multiple-organ dysfunction syndrome           596 (57.8%)   169 (50.3%)   222 (61%)     63 (60%)     89 (60.1%)    53 (67.9%)    0.0108
  SOFA score[^c^](#table-2fn3){ref-type="fn"}   10 (8--13)    8 (6--10.5)   11 (9--13)    9 (7--11)    12 (10--14)   14 (12--16)   \<0.0001
  Thromboembolic event                          174 (16.9%)   45 (13.4%)    68 (18.7%)    23 (21.9%)   20 (13.5%)    18 (23.1%)    0.0617
  Bleeding complication                         284 (27.5%)   69 (20.5%)    117 (32.1%)   26 (24.8%)   43 (29.1%)    29 (37.2%)    0.0026

**Notes.**

Binary data are presented as *n* (%), continuous data as medians (25th to 75th percentile).

Assessed with Pearson's chi-squared test for binary variables and the Kruskal--Wallis test for continuous variables.

At peak of C-reactive protein, not assessable for 271 patients.

Patients in Cluster 1 were characterized by a moderate increase in inflammation and coagulation parameters in comparison to the other clusters describing a milder course of sepsis. The central nervous system was the main underlying disease, while the rate of other comorbidities was low as was the rate of mortality.

Typical for Cluster 2 were decreased levels of antithrombin as well as a relatively low platelet count. A further characteristic of this group was the high rate of renal disease and cardiovascular problems at ICU admission. This group suffered from an increased bleeding rate.

Cluster 3 showed a highly inflammatory course of sepsis with extremely elevated fibrinogen levels and a distinct probable reactive thrombocytosis. These patients frequently showed complications of the intestinal tract. Patients in C3 also exhibited a higher thrombosis rate although the difference was not statistically relevant.

Clusters 4 and 5 exhibited a state of decompensated coagulation and concomitant hyperbilirubinemia. Organ failure and the severity of dysfunction increased, resulting in elevated SOFA scores at the peak level of C-reactive protein. Liver failure frequently occurred in both clusters and was most pronounced in Cluster 5. 53.8% of the patients with a hepatic underlying disease suffered from pre-existing liver cirrhosis and of these patients, 71.4% developed acute-on-cirrhosis liver failure during the septic course (see [File S1](#supp-1){ref-type="supplementary-material"}).

Sepsis severity was characterized by an increasing number of patients with multiple-organ failure towards Cluster 5. The disordered coagulation system resulted in an increased bleeding incidence in Clusters 2, 4 and 5. Especially in Cluster 5 80% of the patients with hepatic failure suffered from impaired liver synthesis and in most cases required vitamin K substitution. The thromboembolic events were most severe in the high inflammatory Cluster 3 and in Cluster 5, although the difference was not statistically significant. In Cluster 5 10.3% of the patients developed disseminated intravascular coagulation (DIC). The length of ICU stay did not significantly differ between clusters (*p* = 0.4085, Kruskal-Wallis rank sum test) and in median (IQR) lasted 14 (7--29) days.

Timeline analysis
-----------------

Since the patient data were collected over a protracted period from 2000 to 2013, the effect of time was investigated. The mortality rate was significantly higher in patients treated before 2005 than in patients treated later.

All types of clusters were present during the entire study duration, but there was a shift in patient numbers in the individual parameter patterns (see [Fig. 4](#fig-4){ref-type="fig"}). The number of patients with the highest survival rate (shown in green in [Fig. 4](#fig-4){ref-type="fig"}) increased over the years. Even when looking at the survival rate in this cluster, the 28-day survival rate was seen to have increased.

![Patient number per cluster in time.\
The proportion of patients (dot) per time period and their respective 28-day mortality (triangle) are depicted for cluster 1 (green), cluster 2 (blue), cluster 3 (golden), cluster 4 (orange), and cluster 5 (red).](peerj-07-7147-g004){#fig-4}

After a peak in the period 2004--2007 the number of patients in the high inflammatory response group (shown in gold in [Fig. 4](#fig-4){ref-type="fig"}) decreased. The number of patients with mild liver failure declined significantly over the entire period, while the number in the group with severe liver failure increased.

Coagulatory and inflammatory parameters associated with survival
----------------------------------------------------------------

A Cox proportional hazards regression model for survival stratified by clusters was fitted ([Fig. 5](#fig-5){ref-type="fig"}) to evaluate the measured parameters with regard to their predictive value regarding the outcome. An increase in fibrinogen levels (100 mg/dl), number of platelets (50 G/l) and PT (10%) as well as a decrease in leukocyte count (5 G/l) was associated with improved 28-day survival.

![Hazard ratios retrieved from the Cox proportional hazards model for survival stratified by clusters.\
Depicted are increases in parameters.](peerj-07-7147-g005){#fig-5}

Discussion
==========

In order to determine which routinely measured parameters of the immune system and the coagulation system are associated with good or poor outcomes with regard to various comorbidities during sepsis, a cluster analysis with subsequent Cox proportional hazards regression model for survival of these clusters was performed. Despite the different clinical features and the constellation of inflammatory and coagulative parameters, four significant parameters remained as independent predictors of survival in our patient population, regardless of the cluster assignment: fibrinogen, platelets, PT, and leukocytes.

Cluster analysis
----------------

The cluster analyses resulted in five different response patterns that interestingly could be attributed to various underlying diseases.

Cluster 1 grouped patients with a low rate of comorbidities and a high probability of survival ([@ref-4]; [@ref-3]). Their response pattern was characterized by a mild inflammatory response and sufficient coagulatory capacity.

Patients in Cluster 2 frequently exhibited renal complications already at ICU admission, which was probably leading to protein loss or the need for hemodialysis with increased consumption of antithrombin ([@ref-22]) and platelets ([@ref-49]; [@ref-32]).

Patients in Cluster 3, who frequently showed complications of the digestive tract, exhibited considerable hyper-inflammation and pronounced thrombocytosis. Thrombocytosis indicates the presence of a severe underlying disease ([@ref-53]) and is associated with soft tissue infection, severe bacterial infection ([@ref-53]; [@ref-12]) and a prothrombotic tendency ([@ref-40]; [@ref-18]). This could be true in our Cluster 3 patients since this group had the highest number of underlying digestive complications associated with a higher thrombosis rate although the difference was not statistically relevant.

Coagulation parameters were lowest in the patients in Clusters 4 and 5, probably as a sign of decompensation and multiple-organ failure, especially failure of the liver with subsequently elevated SOFA scores, resulting in impaired liver synthesis in 80% of all patients with liver failure. About half (53.8%) of the patients suffered from pre-existing liver cirrhosis and 71.4% experienced "acute-on-cirrhosis liver failure." Cirrhosis seems to be a risk factor for developing impaired liver synthesis during sepsis, thus resulting in a higher rate of bleeding complications. Elevated bilirubin levels as surrogate marker for hepatic failure have already been shown to be associated with high mortality ([@ref-9]). The extensive high share of developed cardiac organ failure (76.9%) and renal failure (78%) in Cluster 5 also indicates decompensation.

Hepatic failure leads to impaired synthesis performance resulting in desolate coagulation and declining levels of acute phase proteins in our patients. Prolonged aPTT and decreased PT indicate a hypocoagulant stage; especially low PT values seem to reflect the impaired synthetic capacity of the liver ([@ref-1]). In acute liver failure decreased levels of most coagulation factors are known ([@ref-1]). The antithrombin level decreases more quickly than other coagulation factors ([@ref-55]), thus giving the illusion of a "rebalanced hemostasis" ([@ref-16]; [@ref-27]). However, our septic patients with liver dysfunction showed a significantly increased bleeding rate as well as a trend towards a larger number of thromboembolic complications. These two conflicting complications seem to affect especially patients in Cluster 5, as they have impaired liver synthesis and are developing DIC (10%). Extremely increased monitoring of coagulation is essential for survival in this patient population.

The patients in these clusters are also characterized by lower numbers of platelets and leukocytes. This may be due to septic-induced immunosuppression ([@ref-43]; [@ref-56]), in which patients are unable to make up for the increased consumption of platelets and leukocytes.

Coagulatory and inflammatory parameters associated with survival
----------------------------------------------------------------

Despite the various clinical characteristics and constellation of inflammatory and coagulatory parameters, regardless of the cluster, four significant parameters remained as independent predictors for survival in our patient population, namely fibrinogen, platelets, PT and leukocytes.

An increase in fibrinogen levels per 100 mg/dl was associated with an 11% improvement in survival. The same observation was also made in a previous study ([@ref-10]). Moreover, sepsis animal models have confirmed that high fibrinogen levels are associated with better outcome ([@ref-52]; [@ref-11]; [@ref-29]; [@ref-51]; [@ref-33]). In our septic patient population low fibrinogen levels were associated with poor outcome, even if within the normal range.

Fibrinogen is not only responsible for the fibrin network during coagulation, but also plays a role in inflammation and the innate immune system ([@ref-8]). Both formation of the fibrin network and successive fibrinolysis exhibit an antimicrobial function by first capturing bacteria with subsequent lysis and so preventing further dissemination ([@ref-36]; [@ref-17]; [@ref-28]; [@ref-58]). This can predominantly be observed in bacteria exhibiting fibrinogen binding sites, which is most common in gram-positive bacteria, such as Staphylococcus aureus, and also in some gram-negative bacteria, such as Moraxella catarrhalis ([@ref-36]) or Yersinia enterocolitica ([@ref-29]).

On the other hand, low fibrinogen levels may be due to consumption via fibrin deposition and subsequent disseminated intravascular coagulation (DIC) as well as multiple-organ dysfunction including liver damage ([@ref-42]; [@ref-37]). During liver failure the synthesis of fibrinogen is impaired ([@ref-34]) although in our patients with liver failure the fibrinogen levels were still mainly within or slightly above the normal range, but associated with poor outcome.

Thrombocytopenia during sepsis was associated with higher mortality, whereas the survival rate increased by 14% per 50 G/L of thrombocytes. A previous study revealed that the independent risk factors for thrombocytopenia during septic shock might be several comorbidities such as immunosuppression and liver cirrhosis, but are also assessed with severity of disease and site of infection ([@ref-54]). Platelets are not only consumed by coagulation, but also by their immunological actions ([@ref-15]; [@ref-20]; [@ref-48]).

Another parameter associated with a 15% improvement in survival when rising was the prothrombin time (PT) of 10%, namely independently of the cluster to which the patient was assigned. In some infectious diseases prothrombin time seems to be an important predictor for severe complications ([@ref-7]) and mortality in septic shock ([@ref-19]). Although the leukocyte count was described as a very weak prognostic marker for the survival of sepsis ([@ref-50]), we observed better survival in patients with fewer leukocytes.

Overall, coagulatory parameters appear to be well-suited for stratification of sepsis patients, particularly fibrinogen and platelets. Among other things, when both are elevated, they have a diagnostic value and may indicate a multi-pathogenic infection. When patients suffer from liver dysfunction, this is well reflected in prolonged aPTT, reduced PT and elevated bilirubin levels. In sepsis, a high fibrinogen level is associated with better survival while thrombocytopenia, leukocytosis, and low PT levels are associated with increased mortality. However, C-reactive protein and antithrombin appear to be unspecific for the stratification of septic patients.

Timeline analysis
-----------------

Patient data were collected over a protracted period from 2000 to 2013, and an effect of time on mortality is given. The mortality rate was significantly higher in patients treated before 2005 than in patients treated later. The decline in mortality rates among patients with sepsis was also observed in other studies ([@ref-30]; [@ref-2]; [@ref-21]). In our study, all types of clusters were present during the entire study duration, but patient numbers shifted in the various parameter patterns.

The number of patients with the highest survival rate increased over the years, reflecting advanced therapy strategies. Interestingly, the number of patients with mild liver failure significantly decreased over the entire period, while the number in the group with severe liver failure increased. This is in accordance with other studies that showed that although the overall mortality from sepsis decreased, there was also a shift towards increased severity of sepsis and the number of organ failures ([@ref-21]; [@ref-57]).

This development of an increased survival rate is probably attributed to early and improved treatment of sepsis in order to not let sepsis become severe or the patients are able to survive until an extremely severe stage of disease when those patients are unresponsive to further therapy. This is supported by the fact that the cluster with severe liver failures shows the most distinct shift towards increasing mortality.

Limitations
===========

This study is limited in several aspects. The respective design of the study does not allow any assessment of causal relationships and merely gives associations. Nonetheless, the important role of a coagulatory situation, especially the high levels of fibrinogen and platelets related to improved outcome of sepsis, can be well explained by recently reported pathophysiological mechanisms. Furthermore, not all of the investigated parameters were available in every patient at the C-reactive protein peak. A prospective design would lower the number of missing values as well as offer the possibility to infer causality.

Conclusion
==========

The link between inflammation and coagulation plays a crucial role in critically ill patients with sepsis. Fibrinogen and platelets can serve as parameters for patient stratification during sepsis. When both are elevated, they also have a diagnostic value and may hint at a multi-pathogenic infection in the abdominal area. When patients suffer from liver impairment, this is well reflected in a prolonged aPTT, decreased PT and increased levels of bilirubin. C-reactive protein and antithrombin, however, seem to be unspecific for stratification of septic patients.

An increase in fibrinogen, platelets and PT is linked to survival independently of disease severity. Leukocytes are associated with increased survival in sepsis when declining.

In summary, good survival in sepsis is predicted better by a good coagulatory state than by the inflammatory situation reflected by C-reactive protein levels. The development of disease can be better followed by coagulation parameters than by inflammatory variables, except for leukocytes.
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